Bluefin Capital Management’s CVS Health CVS Stock Holding History

Bluefin Capital Management’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-50,100	Closed	-$1.5K	–	172
2023 Q4	$1.5K	Buy	+50,100	New	+$3.57M	﹤0.01%	224
2022 Q4	–	Sell	-81,900	Closed	-$31K	–	551
2022 Q3	$31K	Buy	+81,900	New	+$8.11M	﹤0.01%	412
2019 Q2	–	Sell	-85,800	Closed	-$3K	–	360
2019 Q1	$3K	Sell	85,800 -14,200	-14%	-$876K	﹤0.01%	378
2018 Q4	$66K	Buy	100,000 +70,000	+233%	+$5.23M	0.01%	296
2018 Q3	$75K	Hold	30,000	–	–	0.01%	368
2018 Q2	$21K	Sell	30,000 -25,000	-45%	-$1.65M	﹤0.01%	373
2018 Q1	$26K	Buy	+55,000	New	+$3.95M	﹤0.01%	363
2016 Q3	–	Sell	-15,200	Closed	-$15K	–	466
2016 Q2	$15K	Buy	+15,200	New	+$1.51M	﹤0.01%	412
2015 Q2	–	Sell	-255,000	Closed	-$1.14M	–	462
2015 Q1	$1.14M	Buy	+255,000	New	+$25.8M	0.1%	166

Other funds holding CVS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bluefin Capital Management's CVS Position: Q1 2026 in Review

Bluefin Capital Management sold out of CVS Health (CVS) in Q1 2026, closing a stake of 8,000 shares — an estimated $635K sold.

Bluefin Capital Management first reported a position in CVS in Q2 2013 and held it in 19 quarters. The position peaked at $14.8M in Q4 2018. 1,868 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

Bluefin Capital Management reported no remaining CVS Health position as of Q1 2026 after selling out during the quarter.
Bluefin Capital Management sold 8,000 CVS Health shares in Q1 2026, an estimated $635K.
Bluefin Capital Management first reported a position in CVS Health in Q2 2013 and held it in 19 quarters.
Bluefin Capital Management's CVS Health position peaked at $14.8M in Q4 2018.
1,868 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Bluefin Capital Management's 13F filing for Q1 2026, filed 15 May 2026.